GlaxoSmithKline Plc - SWOT, Strategy and Corporate Finance Report
Published: June 2013 · Publisher: MarketLine
GlaxoSmithKline Plc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
GlaxoSmithKline Plc - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for GlaxoSmithKline Plc
- Intelligence on GlaxoSmithKline Plcnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
GlaxoSmithKline Plc (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company operates in more than 100 countries and its products are sold in about 150 countries. GSK is headquartered in Brentford, the UK, and employed 99,488 people as of December 31, 2012. The company recorded revenues of £26,431 million ($41,885.2 million*) during the financial year ended December 2012 (FY2012), a decrease of 3.5% over FY2011. The operating profit of the company was £7,392 million ($11,714.1 million*) in FY2012, a decrease of 5.3% over FY2011. The net profit was £4,565 million ($7,234.2 million*) in FY2012, a decrease of 13.2% over FY2011. *Calculated using a constant conversion rate of £1 = $1.5847 for the financial year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects
Features:
- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for GlaxoSmithKline Plc
- Intelligence on GlaxoSmithKline Plcnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
GlaxoSmithKline Plc (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company operates in more than 100 countries and its products are sold in about 150 countries. GSK is headquartered in Brentford, the UK, and employed 99,488 people as of December 31, 2012. The company recorded revenues of £26,431 million ($41,885.2 million*) during the financial year ended December 2012 (FY2012), a decrease of 3.5% over FY2011. The operating profit of the company was £7,392 million ($11,714.1 million*) in FY2012, a decrease of 5.3% over FY2011. The net profit was £4,565 million ($7,234.2 million*) in FY2012, a decrease of 13.2% over FY2011. *Calculated using a constant conversion rate of £1 = $1.5847 for the financial year ended December 31, 2012.
Reasons to Purchase:
- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
GlaxoSmithKline Plc: Company Overview
GlaxoSmithKline Plc: Overview and Key Facts
GlaxoSmithKline Plc: Overview
GlaxoSmithKline Plc: Key Facts
GlaxoSmithKline Plc: Key Employees
GlaxoSmithKline Plc: Key Employee Biographies
GlaxoSmithKline Plc: Major Products and Services
GlaxoSmithKline Plc: Company History
GlaxoSmithKline Plc: Management Statement
GlaxoSmithKline Plc: Locations and Subsidiaries
GlaxoSmithKline Plc: Key Competitors
GlaxoSmithKline Plc: Company Analysis
GlaxoSmithKline Plc: Business Description
GlaxoSmithKline Plc: SWOT Analysis
GlaxoSmithKline Plc: SWOT Overview
GlaxoSmithKline Plc: Strengths
GlaxoSmithKline Plc: Weaknesses
GlaxoSmithKline Plc: Opportunities
GlaxoSmithKline Plc: Threats
GlaxoSmithKline Plc: Financial Analysis
GlaxoSmithKline Plc: Financial Overview
GlaxoSmithKline Plc: Five Year Company Financials
GlaxoSmithKline Plc: Key Income Statement Data
GlaxoSmithKline Plc: Key Balance Sheet Data
GlaxoSmithKline Plc: Key Cash Flow Data
GlaxoSmithKline Plc: Key Market Data
GlaxoSmithKline Plc: Valuation Ratios
GlaxoSmithKline Plc: Profitability Ratios
GlaxoSmithKline Plc: Management Efficiency Ratios
GlaxoSmithKline Plc: Financial Strength Ratios
GlaxoSmithKline Plc: Operational Efficiency Ratios
GlaxoSmithKline Plc: Others
GlaxoSmithKline Plc: Corporate Financial Deals Activity
GlaxoSmithKline Plc: Financial Deals Overview
GlaxoSmithKline Plc: Targets and Partners
GlaxoSmithKline Plc: Top Deals 2009 - 2013YTD*
GlaxoSmithKline Plc: Advisors
GlaxoSmithKline Plc: Top Legal Advisors
GlaxoSmithKline Plc: Top Financial Advisors
GlaxoSmithKline Plc: Mergers and Acquisitions
GlaxoSmithKline Plc: Corporate Venturing
GlaxoSmithKline Plc: Capital Raising
GlaxoSmithKline Plc: Partnership
GlaxoSmithKline Plc: Divestments
GlaxoSmithKline Plc: Recent Developments
GlaxoSmithKline Plc: News and Events Summary
GlaxoSmithKline Plc: Business Expansion
GlaxoSmithKline Plc: Contracts
GlaxoSmithKline Plc: Financial Deals
GlaxoSmithKline Plc: Regulatory and Legal Events
GlaxoSmithKline Plc: Research & Development
GlaxoSmithKline Plc: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Key Income Statement Data
Table 6: GlaxoSmithKline Plc: Key Balance Sheet Data
Table 7: GlaxoSmithKline Plc: Key Cash Flow Data
Table 8: GlaxoSmithKline Plc: Key Market Data
Table 9: GlaxoSmithKline Plc: Key Growth Ratios
Table 10: GlaxoSmithKline Plc: Valuation Ratios
Table 11: GlaxoSmithKline Plc: Profitability Ratios
Table 12: GlaxoSmithKline Plc: Management Efficiency Ratios
Table 13: GlaxoSmithKline Plc: Financial Strength Ratios
Table 14: GlaxoSmithKline Plc: Operational Efficiency Ratios
Table 15: GlaxoSmithKline Plc: Others
Table 16: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 17: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 18: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 20: GlaxoSmithKline Plc: Targets and Partners
Table 21: GlaxoSmithKline Plc: Top Deals 2009 - 2013YTD*
Table 22: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 23: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 24: GlaxoSmithKline Plc: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: GlaxoSmithKline Plc: M&A Activity by Geography (2009 - YTD*2013)
Table 26: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: GlaxoSmithKline Plc: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 29: GlaxoSmithKline Plc: Capital Raising by Deal Type (2009 - YTD*2013)
Table 30: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 31: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 32: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 33: GlaxoSmithKline Plc: Divestments by Geography (2009 - YTD*2013)
Table 34: GlaxoSmithKline Plc: News and Events Summary
Table 35: GlaxoSmithKline Plc: Business Expansion
Table 36: GlaxoSmithKline Plc: Contracts
Table 37: GlaxoSmithKline Plc: Financial Deals
Table 38: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 39: GlaxoSmithKline Plc: Research & Development
Table 40: GlaxoSmithKline Plc: Strategy and Operations
List of Figures
Figure 1: GlaxoSmithKline Plc: Revenue to Net Income (2007-2011)
Figure 2: GlaxoSmithKline Plc: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: GlaxoSmithKline Plc: Current Assets to Current Liabilities (2007-2011)
Figure 4: GlaxoSmithKline Plc: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: GlaxoSmithKline Plc: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: GlaxoSmithKline Plc: Net Change in Cash (2007-2011)
Figure 7: GlaxoSmithKline Plc: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: GlaxoSmithKline Plc: Enterprise Value (2007-2011)
Figure 9: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 11: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: GlaxoSmithKline Plc: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 22: GlaxoSmithKline Plc: Divestments by Geography (2009 - YTD*2013)
GlaxoSmithKline Plc: Company Overview
GlaxoSmithKline Plc: Overview and Key Facts
GlaxoSmithKline Plc: Overview
GlaxoSmithKline Plc: Key Facts
GlaxoSmithKline Plc: Key Employees
GlaxoSmithKline Plc: Key Employee Biographies
GlaxoSmithKline Plc: Major Products and Services
GlaxoSmithKline Plc: Company History
GlaxoSmithKline Plc: Management Statement
GlaxoSmithKline Plc: Locations and Subsidiaries
GlaxoSmithKline Plc: Key Competitors
GlaxoSmithKline Plc: Company Analysis
GlaxoSmithKline Plc: Business Description
GlaxoSmithKline Plc: SWOT Analysis
GlaxoSmithKline Plc: SWOT Overview
GlaxoSmithKline Plc: Strengths
GlaxoSmithKline Plc: Weaknesses
GlaxoSmithKline Plc: Opportunities
GlaxoSmithKline Plc: Threats
GlaxoSmithKline Plc: Financial Analysis
GlaxoSmithKline Plc: Financial Overview
GlaxoSmithKline Plc: Five Year Company Financials
GlaxoSmithKline Plc: Key Income Statement Data
GlaxoSmithKline Plc: Key Balance Sheet Data
GlaxoSmithKline Plc: Key Cash Flow Data
GlaxoSmithKline Plc: Key Market Data
GlaxoSmithKline Plc: Valuation Ratios
GlaxoSmithKline Plc: Profitability Ratios
GlaxoSmithKline Plc: Management Efficiency Ratios
GlaxoSmithKline Plc: Financial Strength Ratios
GlaxoSmithKline Plc: Operational Efficiency Ratios
GlaxoSmithKline Plc: Others
GlaxoSmithKline Plc: Corporate Financial Deals Activity
GlaxoSmithKline Plc: Financial Deals Overview
GlaxoSmithKline Plc: Targets and Partners
GlaxoSmithKline Plc: Top Deals 2009 - 2013YTD*
GlaxoSmithKline Plc: Advisors
GlaxoSmithKline Plc: Top Legal Advisors
GlaxoSmithKline Plc: Top Financial Advisors
GlaxoSmithKline Plc: Mergers and Acquisitions
GlaxoSmithKline Plc: Corporate Venturing
GlaxoSmithKline Plc: Capital Raising
GlaxoSmithKline Plc: Partnership
GlaxoSmithKline Plc: Divestments
GlaxoSmithKline Plc: Recent Developments
GlaxoSmithKline Plc: News and Events Summary
GlaxoSmithKline Plc: Business Expansion
GlaxoSmithKline Plc: Contracts
GlaxoSmithKline Plc: Financial Deals
GlaxoSmithKline Plc: Regulatory and Legal Events
GlaxoSmithKline Plc: Research & Development
GlaxoSmithKline Plc: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Key Income Statement Data
Table 6: GlaxoSmithKline Plc: Key Balance Sheet Data
Table 7: GlaxoSmithKline Plc: Key Cash Flow Data
Table 8: GlaxoSmithKline Plc: Key Market Data
Table 9: GlaxoSmithKline Plc: Key Growth Ratios
Table 10: GlaxoSmithKline Plc: Valuation Ratios
Table 11: GlaxoSmithKline Plc: Profitability Ratios
Table 12: GlaxoSmithKline Plc: Management Efficiency Ratios
Table 13: GlaxoSmithKline Plc: Financial Strength Ratios
Table 14: GlaxoSmithKline Plc: Operational Efficiency Ratios
Table 15: GlaxoSmithKline Plc: Others
Table 16: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 17: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 18: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 20: GlaxoSmithKline Plc: Targets and Partners
Table 21: GlaxoSmithKline Plc: Top Deals 2009 - 2013YTD*
Table 22: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 23: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 24: GlaxoSmithKline Plc: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: GlaxoSmithKline Plc: M&A Activity by Geography (2009 - YTD*2013)
Table 26: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: GlaxoSmithKline Plc: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 29: GlaxoSmithKline Plc: Capital Raising by Deal Type (2009 - YTD*2013)
Table 30: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 31: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 32: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 33: GlaxoSmithKline Plc: Divestments by Geography (2009 - YTD*2013)
Table 34: GlaxoSmithKline Plc: News and Events Summary
Table 35: GlaxoSmithKline Plc: Business Expansion
Table 36: GlaxoSmithKline Plc: Contracts
Table 37: GlaxoSmithKline Plc: Financial Deals
Table 38: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 39: GlaxoSmithKline Plc: Research & Development
Table 40: GlaxoSmithKline Plc: Strategy and Operations
List of Figures
Figure 1: GlaxoSmithKline Plc: Revenue to Net Income (2007-2011)
Figure 2: GlaxoSmithKline Plc: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: GlaxoSmithKline Plc: Current Assets to Current Liabilities (2007-2011)
Figure 4: GlaxoSmithKline Plc: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: GlaxoSmithKline Plc: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: GlaxoSmithKline Plc: Net Change in Cash (2007-2011)
Figure 7: GlaxoSmithKline Plc: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: GlaxoSmithKline Plc: Enterprise Value (2007-2011)
Figure 9: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 11: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: GlaxoSmithKline Plc: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 22: GlaxoSmithKline Plc: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.